

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.12046957 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.12046957 |
| 3 | establishment of integrated proviral latency (GO:0075713) | 5.95264217 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.94831043 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.94831043 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.79339419 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.40284561 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.36379708 |
| 9 | sulfur amino acid catabolic process (GO:0000098) | 5.20179729 |
| 10 | cysteine metabolic process (GO:0006534) | 5.14127328 |
| 11 | glyoxylate metabolic process (GO:0046487) | 4.91233546 |
| 12 | lysine metabolic process (GO:0006553) | 4.85913785 |
| 13 | lysine catabolic process (GO:0006554) | 4.85913785 |
| 14 | urea metabolic process (GO:0019627) | 4.83236687 |
| 15 | urea cycle (GO:0000050) | 4.83236687 |
| 16 | kynurenine metabolic process (GO:0070189) | 4.80659334 |
| 17 | bile acid biosynthetic process (GO:0006699) | 4.75793289 |
| 18 | tryptophan catabolic process (GO:0006569) | 4.70330165 |
| 19 | indole-containing compound catabolic process (GO:0042436) | 4.70330165 |
| 20 | indolalkylamine catabolic process (GO:0046218) | 4.70330165 |
| 21 | homocysteine metabolic process (GO:0050667) | 4.64540114 |
| 22 | establishment of viral latency (GO:0019043) | 4.63523561 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.62877420 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 4.58246355 |
| 25 | tryptophan metabolic process (GO:0006568) | 4.47177757 |
| 26 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.41935562 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.40187123 |
| 28 | regulation of triglyceride catabolic process (GO:0010896) | 4.37455263 |
| 29 | complement activation, alternative pathway (GO:0006957) | 4.36269360 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.30845018 |
| 31 | protein carboxylation (GO:0018214) | 4.30845018 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 4.29378819 |
| 33 | negative regulation of sterol transport (GO:0032372) | 4.25540029 |
| 34 | negative regulation of cholesterol transport (GO:0032375) | 4.25540029 |
| 35 | DNA strand elongation (GO:0022616) | 4.25391249 |
| 36 | ribosome assembly (GO:0042255) | 4.24338213 |
| 37 | regulation of cholesterol homeostasis (GO:2000188) | 4.21821592 |
| 38 | serine family amino acid catabolic process (GO:0009071) | 4.21399099 |
| 39 | bile acid metabolic process (GO:0008206) | 4.18805615 |
| 40 | intestinal cholesterol absorption (GO:0030299) | 4.18726394 |
| 41 | reverse cholesterol transport (GO:0043691) | 4.16391474 |
| 42 | triglyceride homeostasis (GO:0070328) | 4.11768129 |
| 43 | acylglycerol homeostasis (GO:0055090) | 4.11768129 |
| 44 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.10278821 |
| 45 | regulation of protein activation cascade (GO:2000257) | 4.10131496 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.09316362 |
| 47 | protein localization to kinetochore (GO:0034501) | 4.08091266 |
| 48 | protein localization to chromosome, centromeric region (GO:0071459) | 4.05762609 |
| 49 | DNA unwinding involved in DNA replication (GO:0006268) | 4.01978245 |
| 50 | mitotic metaphase plate congression (GO:0007080) | 4.01950414 |
| 51 | cellular modified amino acid catabolic process (GO:0042219) | 4.01337284 |
| 52 | plasma lipoprotein particle clearance (GO:0034381) | 4.00322643 |
| 53 | mitotic chromosome condensation (GO:0007076) | 3.97901426 |
| 54 | drug catabolic process (GO:0042737) | 3.96002981 |
| 55 | protein-lipid complex remodeling (GO:0034368) | 3.95105263 |
| 56 | macromolecular complex remodeling (GO:0034367) | 3.95105263 |
| 57 | plasma lipoprotein particle remodeling (GO:0034369) | 3.95105263 |
| 58 | nuclear pore complex assembly (GO:0051292) | 3.91345775 |
| 59 | regulation of fibrinolysis (GO:0051917) | 3.90305555 |
| 60 | aromatic amino acid family metabolic process (GO:0009072) | 3.89987714 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 3.89379258 |
| 62 | mitotic sister chromatid segregation (GO:0000070) | 3.89031905 |
| 63 | regulation of complement activation (GO:0030449) | 3.88535729 |
| 64 | alpha-amino acid catabolic process (GO:1901606) | 3.88415760 |
| 65 | ethanol oxidation (GO:0006069) | 3.88004383 |
| 66 | valine metabolic process (GO:0006573) | 3.84277012 |
| 67 | tyrosine metabolic process (GO:0006570) | 3.82553121 |
| 68 | acetyl-CoA metabolic process (GO:0006084) | 3.80584690 |
| 69 | cellular glucuronidation (GO:0052695) | 3.77766823 |
| 70 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.77208797 |
| 71 | glutamate metabolic process (GO:0006536) | 3.76919685 |
| 72 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.76905461 |
| 73 | drug transmembrane transport (GO:0006855) | 3.76555748 |
| 74 | regulation of cholesterol esterification (GO:0010872) | 3.75592985 |
| 75 | phospholipid efflux (GO:0033700) | 3.75156646 |
| 76 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.74419005 |
| 77 | cellular amino acid catabolic process (GO:0009063) | 3.74100417 |
| 78 | intestinal absorption (GO:0050892) | 3.73030673 |
| 79 | serine family amino acid metabolic process (GO:0009069) | 3.70993004 |
| 80 | bile acid and bile salt transport (GO:0015721) | 3.70230519 |
| 81 | 2-oxoglutarate metabolic process (GO:0006103) | 3.69784271 |
| 82 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.68585518 |
| 83 | positive regulation of lipid catabolic process (GO:0050996) | 3.68120874 |
| 84 | DNA ligation (GO:0006266) | 3.67581518 |
| 85 | glycine metabolic process (GO:0006544) | 3.67158047 |
| 86 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.65749192 |
| 87 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.64040899 |
| 88 | benzene-containing compound metabolic process (GO:0042537) | 3.62657584 |
| 89 | cholesterol efflux (GO:0033344) | 3.62335368 |
| 90 | fatty acid beta-oxidation (GO:0006635) | 3.61171513 |
| 91 | short-chain fatty acid metabolic process (GO:0046459) | 3.60748791 |
| 92 | low-density lipoprotein particle clearance (GO:0034383) | 3.60351199 |
| 93 | serine family amino acid biosynthetic process (GO:0009070) | 3.58512884 |
| 94 | CENP-A containing nucleosome assembly (GO:0034080) | 3.58136192 |
| 95 | coenzyme catabolic process (GO:0009109) | 3.56324532 |
| 96 | formation of translation preinitiation complex (GO:0001731) | 3.55985665 |
| 97 | fatty acid oxidation (GO:0019395) | 3.55902146 |
| 98 | plasma lipoprotein particle assembly (GO:0034377) | 3.55028668 |
| 99 | proteasome assembly (GO:0043248) | 3.54910466 |
| 100 | sister chromatid segregation (GO:0000819) | 3.54599363 |
| 101 | telomere maintenance via recombination (GO:0000722) | 3.54154948 |
| 102 | chromatin remodeling at centromere (GO:0031055) | 3.52526568 |
| 103 | lipoprotein metabolic process (GO:0042157) | 3.51997149 |
| 104 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.50762189 |
| 105 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.49279334 |
| 106 | epoxygenase P450 pathway (GO:0019373) | 3.48232537 |
| 107 | phospholipid homeostasis (GO:0055091) | 3.48189931 |
| 108 | lipid oxidation (GO:0034440) | 3.48037023 |
| 109 | cholesterol homeostasis (GO:0042632) | 3.46235930 |
| 110 | sterol homeostasis (GO:0055092) | 3.45367342 |
| 111 | negative regulation of ligase activity (GO:0051352) | 3.44550959 |
| 112 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.44550959 |
| 113 | non-recombinational repair (GO:0000726) | 3.43645389 |
| 114 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.43645389 |
| 115 | mitotic recombination (GO:0006312) | 3.43589171 |
| 116 | nuclear pore organization (GO:0006999) | 3.42886251 |
| 117 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.42823238 |
| 118 | regulation of mitochondrial translation (GO:0070129) | 3.40267875 |
| 119 | flavonoid metabolic process (GO:0009812) | 3.39648438 |
| 120 | ketone body metabolic process (GO:1902224) | 3.38788518 |
| 121 | aspartate family amino acid catabolic process (GO:0009068) | 3.38128836 |
| 122 | uronic acid metabolic process (GO:0006063) | 3.37519344 |
| 123 | glucuronate metabolic process (GO:0019585) | 3.37519344 |
| 124 | fatty acid catabolic process (GO:0009062) | 3.36241787 |
| 125 | organic acid catabolic process (GO:0016054) | 3.35889795 |
| 126 | carboxylic acid catabolic process (GO:0046395) | 3.35889795 |
| 127 | purine nucleobase biosynthetic process (GO:0009113) | 3.35882338 |
| 128 | protein-lipid complex assembly (GO:0065005) | 3.35007750 |
| 129 | monocarboxylic acid catabolic process (GO:0072329) | 3.34789405 |
| 130 | indolalkylamine metabolic process (GO:0006586) | 3.34541497 |
| 131 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.33533169 |
| 132 | IMP biosynthetic process (GO:0006188) | 3.33475696 |
| 133 | urate metabolic process (GO:0046415) | 3.33275502 |
| 134 | metaphase plate congression (GO:0051310) | 3.30410497 |
| 135 | drug metabolic process (GO:0017144) | 3.27603744 |
| 136 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.26540387 |
| 137 | regulation of sister chromatid cohesion (GO:0007063) | 3.26048566 |
| 138 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.23557272 |
| 139 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.22110927 |
| 140 | regulation of translational fidelity (GO:0006450) | 3.18552386 |
| 141 | mitotic nuclear envelope disassembly (GO:0007077) | 3.17205462 |
| 142 | ribosomal large subunit biogenesis (GO:0042273) | 3.16956159 |
| 143 | nucleobase biosynthetic process (GO:0046112) | 3.13432205 |
| 144 | spliceosomal snRNP assembly (GO:0000387) | 3.12145945 |
| 145 | maturation of SSU-rRNA (GO:0030490) | 3.09973724 |
| 146 | DNA replication initiation (GO:0006270) | 3.09495199 |
| 147 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.05835506 |
| 148 | DNA replication checkpoint (GO:0000076) | 3.04790728 |
| 149 | DNA topological change (GO:0006265) | 3.04455718 |
| 150 | spindle checkpoint (GO:0031577) | 3.01244904 |
| 151 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.96774739 |
| 152 | regulation of translational termination (GO:0006449) | 2.94641435 |
| 153 | proline biosynthetic process (GO:0006561) | 2.94296765 |
| 154 | nuclear envelope disassembly (GO:0051081) | 2.93905948 |
| 155 | membrane disassembly (GO:0030397) | 2.93905948 |
| 156 | regulation of chromosome segregation (GO:0051983) | 2.93729728 |
| 157 | positive regulation of ligase activity (GO:0051351) | 2.93392975 |
| 158 | maturation of 5.8S rRNA (GO:0000460) | 2.92423411 |
| 159 | DNA damage response, detection of DNA damage (GO:0042769) | 2.91152925 |
| 160 | Golgi transport vesicle coating (GO:0048200) | 2.90606776 |
| 161 | COPI coating of Golgi vesicle (GO:0048205) | 2.90606776 |
| 162 | mitotic spindle checkpoint (GO:0071174) | 2.90189880 |
| 163 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.89290089 |
| 164 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.89290089 |
| 165 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.89290089 |
| 166 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.88776580 |
| 167 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.88776580 |
| 168 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.88628091 |
| 169 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.88628091 |
| 170 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.88306603 |
| 171 | tRNA aminoacylation for protein translation (GO:0006418) | 2.88264954 |
| 172 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.87834756 |
| 173 | tRNA aminoacylation (GO:0043039) | 2.87182047 |
| 174 | amino acid activation (GO:0043038) | 2.87182047 |
| 175 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.86664113 |
| 176 | histone exchange (GO:0043486) | 2.85109598 |
| 177 | cell cycle G1/S phase transition (GO:0044843) | 2.85019663 |
| 178 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.85019663 |
| 179 | IMP metabolic process (GO:0046040) | 2.84821276 |
| 180 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.84491720 |
| 181 | establishment of chromosome localization (GO:0051303) | 2.84172597 |
| 182 | telomere maintenance via telomere lengthening (GO:0010833) | 2.83846382 |
| 183 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.83496756 |
| 184 | ribosome biogenesis (GO:0042254) | 2.83021489 |
| 185 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.82827667 |
| 186 | regulation of mitotic spindle organization (GO:0060236) | 2.82403786 |
| 187 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.82130452 |
| 188 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.81708300 |
| 189 | DNA replication-independent nucleosome organization (GO:0034724) | 2.80902951 |
| 190 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.80902951 |
| 191 | regulation of spindle organization (GO:0090224) | 2.80580283 |
| 192 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.80420919 |
| 193 | positive regulation of chromosome segregation (GO:0051984) | 2.79779178 |
| 194 | regulation of ligase activity (GO:0051340) | 2.78543745 |
| 195 | regulation of cofactor metabolic process (GO:0051193) | 2.77111799 |
| 196 | regulation of coenzyme metabolic process (GO:0051196) | 2.77111799 |
| 197 | ribosomal small subunit assembly (GO:0000028) | 2.76873420 |
| 198 | L-serine metabolic process (GO:0006563) | 2.76739569 |
| 199 | pore complex assembly (GO:0046931) | 2.76353409 |
| 200 | negative regulation of chromosome segregation (GO:0051985) | 2.75318261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.84775828 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.14915428 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.07292302 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.28465016 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.09053541 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.65628016 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.73850244 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.57422143 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.23706190 |
| 10 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.10694083 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.10480568 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.66152198 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.65607076 |
| 14 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.65213066 |
| 15 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.56488704 |
| 16 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.50532696 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.34164879 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.22745175 |
| 19 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.18977254 |
| 20 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.00404292 |
| 21 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.98964176 |
| 22 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.94491700 |
| 23 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.93968557 |
| 24 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.90038569 |
| 25 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.90035323 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.86057085 |
| 27 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.73961050 |
| 28 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.73770718 |
| 29 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.69255767 |
| 30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.65119928 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.58283746 |
| 32 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.52638651 |
| 33 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.27643885 |
| 34 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.26744698 |
| 35 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.25976481 |
| 36 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.23905006 |
| 37 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.16635083 |
| 38 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.15889850 |
| 39 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.15744904 |
| 40 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.12864162 |
| 41 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 2.12263860 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.06329812 |
| 43 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.05720690 |
| 44 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 2.02769544 |
| 45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.00530405 |
| 46 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 2.00474346 |
| 47 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.98897446 |
| 48 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.98751710 |
| 49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.96727563 |
| 50 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.89443542 |
| 51 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.88780885 |
| 52 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.84878035 |
| 53 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.84357617 |
| 54 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.81188940 |
| 55 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.79801024 |
| 56 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.78664542 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.78005217 |
| 58 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.76703036 |
| 59 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.76341652 |
| 60 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.74545228 |
| 61 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.73946090 |
| 62 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.73094348 |
| 63 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.68609281 |
| 64 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.68542475 |
| 65 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.67305284 |
| 66 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.65668336 |
| 67 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.60279686 |
| 68 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.59207658 |
| 69 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.56671090 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54963525 |
| 71 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45679870 |
| 72 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.44774384 |
| 73 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.44486925 |
| 74 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.42551143 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37847005 |
| 76 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.34470517 |
| 77 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.32612416 |
| 78 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.30578593 |
| 79 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30367893 |
| 80 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.27051635 |
| 81 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.26780974 |
| 82 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.26630096 |
| 83 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.26011620 |
| 84 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.24247111 |
| 85 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23745222 |
| 86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21688685 |
| 87 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21677872 |
| 88 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21365285 |
| 89 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.20440006 |
| 90 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.20126082 |
| 91 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.20020624 |
| 92 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.18707125 |
| 93 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18605321 |
| 94 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.17614830 |
| 95 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15958180 |
| 96 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.15762646 |
| 97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14530272 |
| 98 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.13090118 |
| 99 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.12244936 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12074788 |
| 101 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.12008635 |
| 102 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09458107 |
| 103 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08048326 |
| 104 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.07796366 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07150896 |
| 106 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06170789 |
| 107 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06111610 |
| 108 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05904325 |
| 109 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.05896398 |
| 110 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.05667072 |
| 111 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05142216 |
| 112 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01752972 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01587317 |
| 114 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.01359090 |
| 115 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.01029959 |
| 116 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.00143888 |
| 117 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99794062 |
| 118 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99129284 |
| 119 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.98362409 |
| 120 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.98286404 |
| 121 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97027392 |
| 122 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95650323 |
| 123 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94243147 |
| 124 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.94203778 |
| 125 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92960177 |
| 126 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92252899 |
| 127 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.92232418 |
| 128 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91663281 |
| 129 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91588069 |
| 130 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.90378401 |
| 131 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.90238246 |
| 132 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.89933673 |
| 133 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89859676 |
| 134 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89769386 |
| 135 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.89480799 |
| 136 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.89118623 |
| 137 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88339010 |
| 138 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.88105273 |
| 139 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86943396 |
| 140 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.86346004 |
| 141 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.83136285 |
| 142 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.82637788 |
| 143 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.82550228 |
| 144 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.81778899 |
| 145 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80787651 |
| 146 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.80180324 |
| 147 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.79955840 |
| 148 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.79791126 |
| 149 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.79725463 |
| 150 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.78251188 |
| 151 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77953088 |
| 152 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77495541 |
| 153 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.76971608 |
| 154 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.76963422 |
| 155 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.76650227 |
| 156 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.76635528 |
| 157 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76229251 |
| 158 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.74771050 |
| 159 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.72714254 |
| 160 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70686225 |
| 161 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.70250332 |
| 162 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.70250332 |
| 163 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.69876585 |
| 164 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.69876585 |
| 165 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69730807 |
| 166 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.69319033 |
| 167 | GATA1_19941826_ChIP-Seq_K562_Human | 0.67085018 |
| 168 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.66347960 |
| 169 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.64870292 |
| 170 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.64825977 |
| 171 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.64820386 |
| 172 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.64431586 |
| 173 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.63027252 |
| 174 | GATA2_19941826_ChIP-Seq_K562_Human | 0.62298836 |
| 175 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.61324524 |
| 176 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.61075035 |
| 177 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.60710619 |
| 178 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.59407268 |
| 179 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.59132531 |
| 180 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.58822623 |
| 181 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55009383 |
| 182 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.54150974 |
| 183 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.53557542 |
| 184 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.53026901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.47103586 |
| 2 | MP0005360_urolithiasis | 7.14184017 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.32585363 |
| 4 | MP0005365_abnormal_bile_salt | 5.29842528 |
| 5 | MP0010094_abnormal_chromosome_stability | 4.61008012 |
| 6 | MP0003693_abnormal_embryo_hatching | 4.35843343 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 4.31499263 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 4.30904575 |
| 9 | MP0003111_abnormal_nucleus_morphology | 4.07294220 |
| 10 | MP0003252_abnormal_bile_duct | 3.81933509 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.46747549 |
| 12 | MP0003077_abnormal_cell_cycle | 3.32011341 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 3.21762888 |
| 14 | MP0001666_abnormal_nutrient_absorption | 3.12710272 |
| 15 | MP0008058_abnormal_DNA_repair | 2.92588284 |
| 16 | MP0009840_abnormal_foam_cell | 2.85374576 |
| 17 | MP0008932_abnormal_embryonic_tissue | 2.82079976 |
| 18 | MP0005083_abnormal_biliary_tract | 2.66661224 |
| 19 | MP0005332_abnormal_amino_acid | 2.62708301 |
| 20 | MP0008007_abnormal_cellular_replicative | 2.60013105 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 2.55397856 |
| 22 | MP0003195_calcinosis | 2.41174547 |
| 23 | MP0008057_abnormal_DNA_replication | 2.40960676 |
| 24 | MP0003718_maternal_effect | 2.25289373 |
| 25 | MP0003941_abnormal_skin_development | 2.15202838 |
| 26 | MP0003315_abnormal_perineum_morphology | 2.10701693 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 2.09475548 |
| 28 | MP0001730_embryonic_growth_arrest | 2.06947448 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 2.05818903 |
| 30 | MP0000609_abnormal_liver_physiology | 2.04749271 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 2.00613337 |
| 32 | MP0000350_abnormal_cell_proliferation | 1.93538375 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.88445906 |
| 34 | MP0001293_anophthalmia | 1.82478010 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.77852280 |
| 36 | MP0001697_abnormal_embryo_size | 1.73804689 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.71910356 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.67926109 |
| 39 | MP0003786_premature_aging | 1.67849533 |
| 40 | MP0001672_abnormal_embryogenesis/_devel | 1.66933082 |
| 41 | MP0005380_embryogenesis_phenotype | 1.66933082 |
| 42 | MP0003868_abnormal_feces_composition | 1.63341724 |
| 43 | MP0002080_prenatal_lethality | 1.57116769 |
| 44 | MP0002697_abnormal_eye_size | 1.56771762 |
| 45 | MP0003984_embryonic_growth_retardation | 1.48883411 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.48822412 |
| 47 | MP0002088_abnormal_embryonic_growth/wei | 1.41851035 |
| 48 | MP0002084_abnormal_developmental_patter | 1.41810628 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41719150 |
| 50 | MP0006035_abnormal_mitochondrial_morpho | 1.40664707 |
| 51 | MP0005670_abnormal_white_adipose | 1.40360475 |
| 52 | MP0009379_abnormal_foot_pigmentation | 1.39117711 |
| 53 | MP0002085_abnormal_embryonic_tissue | 1.35639078 |
| 54 | MP0001529_abnormal_vocalization | 1.34643090 |
| 55 | MP0004043_abnormal_pH_regulation | 1.34021017 |
| 56 | MP0005257_abnormal_intraocular_pressure | 1.31242151 |
| 57 | MP0004130_abnormal_muscle_cell | 1.27527639 |
| 58 | MP0003937_abnormal_limbs/digits/tail_de | 1.26452462 |
| 59 | MP0004272_abnormal_basement_membrane | 1.25830583 |
| 60 | MP0001286_abnormal_eye_development | 1.23661722 |
| 61 | MP0002086_abnormal_extraembryonic_tissu | 1.21908747 |
| 62 | MP0003123_paternal_imprinting | 1.21600355 |
| 63 | MP0010030_abnormal_orbit_morphology | 1.21366262 |
| 64 | MP0005666_abnormal_adipose_tissue | 1.20968202 |
| 65 | MP0001346_abnormal_lacrimal_gland | 1.19810003 |
| 66 | MP0000358_abnormal_cell_content/ | 1.19747788 |
| 67 | MP0002233_abnormal_nose_morphology | 1.18280406 |
| 68 | MP0002092_abnormal_eye_morphology | 1.18176253 |
| 69 | MP0004197_abnormal_fetal_growth/weight/ | 1.18041328 |
| 70 | MP0001764_abnormal_homeostasis | 1.17286126 |
| 71 | MP0000313_abnormal_cell_death | 1.16342302 |
| 72 | MP0004264_abnormal_extraembryonic_tissu | 1.16010891 |
| 73 | MP0000762_abnormal_tongue_morphology | 1.15749756 |
| 74 | MP0001756_abnormal_urination | 1.15722623 |
| 75 | MP0000598_abnormal_liver_morphology | 1.13971926 |
| 76 | MP0005501_abnormal_skin_physiology | 1.12790875 |
| 77 | MP0003890_abnormal_embryonic-extraembry | 1.12490841 |
| 78 | MP0003186_abnormal_redox_activity | 1.11917295 |
| 79 | MP0005220_abnormal_exocrine_pancreas | 1.10951182 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 1.08489130 |
| 81 | MP0005636_abnormal_mineral_homeostasis | 1.07297037 |
| 82 | MP0002938_white_spotting | 1.06349400 |
| 83 | MP0009780_abnormal_chondrocyte_physiolo | 1.04763670 |
| 84 | MP0000490_abnormal_crypts_of | 1.02963966 |
| 85 | MP0002234_abnormal_pharynx_morphology | 1.02349773 |
| 86 | MP0003385_abnormal_body_wall | 1.02235664 |
| 87 | MP0002111_abnormal_tail_morphology | 1.01792783 |
| 88 | MP0004185_abnormal_adipocyte_glucose | 0.97729589 |
| 89 | MP0002160_abnormal_reproductive_system | 0.97045844 |
| 90 | MP0002971_abnormal_brown_adipose | 0.92335908 |
| 91 | MP0005334_abnormal_fat_pad | 0.91433638 |
| 92 | MP0005084_abnormal_gallbladder_morpholo | 0.91386980 |
| 93 | MP0000604_amyloidosis | 0.90814273 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.88768206 |
| 95 | MP0003567_abnormal_fetal_cardiomyocyte | 0.88507014 |
| 96 | MP0009053_abnormal_anal_canal | 0.88471295 |
| 97 | MP0010352_gastrointestinal_tract_polyps | 0.88104577 |
| 98 | MP0002909_abnormal_adrenal_gland | 0.87895216 |
| 99 | MP0003119_abnormal_digestive_system | 0.86935156 |
| 100 | MP0000627_abnormal_mammary_gland | 0.85949502 |
| 101 | MP0010307_abnormal_tumor_latency | 0.85712944 |
| 102 | MP0001915_intracranial_hemorrhage | 0.83497857 |
| 103 | MP0009642_abnormal_blood_homeostasis | 0.83412870 |
| 104 | MP0003943_abnormal_hepatobiliary_system | 0.83127561 |
| 105 | MP0005375_adipose_tissue_phenotype | 0.82711866 |
| 106 | MP0005448_abnormal_energy_balance | 0.82584006 |
| 107 | MP0006292_abnormal_olfactory_placode | 0.81987651 |
| 108 | MP0006072_abnormal_retinal_apoptosis | 0.81919787 |
| 109 | MP0005647_abnormal_sex_gland | 0.81295521 |
| 110 | MP0002210_abnormal_sex_determination | 0.79715358 |
| 111 | MP0005408_hypopigmentation | 0.79280905 |
| 112 | MP0010368_abnormal_lymphatic_system | 0.78317174 |
| 113 | MP0000566_synostosis | 0.77551744 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.76161960 |
| 115 | MP0002019_abnormal_tumor_incidence | 0.75914039 |
| 116 | MP0003283_abnormal_digestive_organ | 0.75568304 |
| 117 | MP0002254_reproductive_system_inflammat | 0.75281710 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.74652922 |
| 119 | MP0008438_abnormal_cutaneous_collagen | 0.73594922 |
| 120 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73188502 |
| 121 | MP0001944_abnormal_pancreas_morphology | 0.72906011 |
| 122 | MP0005535_abnormal_body_temperature | 0.72859692 |
| 123 | MP0001929_abnormal_gametogenesis | 0.72815812 |
| 124 | MP0004233_abnormal_muscle_weight | 0.72451248 |
| 125 | MP0000537_abnormal_urethra_morphology | 0.72411206 |
| 126 | MP0001727_abnormal_embryo_implantation | 0.72380893 |
| 127 | MP0002877_abnormal_melanocyte_morpholog | 0.72096557 |
| 128 | MP0002089_abnormal_postnatal_growth/wei | 0.71958527 |
| 129 | MP0009697_abnormal_copulation | 0.71714814 |
| 130 | MP0003121_genomic_imprinting | 0.71425689 |
| 131 | MP0002006_tumorigenesis | 0.71355267 |
| 132 | MP0005384_cellular_phenotype | 0.70377254 |
| 133 | MP0009763_increased_sensitivity_to | 0.69381391 |
| 134 | MP0010678_abnormal_skin_adnexa | 0.68677350 |
| 135 | MP0001661_extended_life_span | 0.68099146 |
| 136 | MP0005391_vision/eye_phenotype | 0.68028410 |
| 137 | MP0001145_abnormal_male_reproductive | 0.67364187 |
| 138 | MP0002796_impaired_skin_barrier | 0.65679956 |
| 139 | MP0009764_decreased_sensitivity_to | 0.65288516 |
| 140 | MP0001340_abnormal_eyelid_morphology | 0.64940765 |
| 141 | MP0005058_abnormal_lysosome_morphology | 0.64394331 |
| 142 | MP0008961_abnormal_basal_metabolism | 0.64340932 |
| 143 | MP0003959_abnormal_lean_body | 0.64027986 |
| 144 | MP0003656_abnormal_erythrocyte_physiolo | 0.62776524 |
| 145 | MP0001881_abnormal_mammary_gland | 0.62158493 |
| 146 | MP0003953_abnormal_hormone_level | 0.61651733 |
| 147 | MP0000013_abnormal_adipose_tissue | 0.61426358 |
| 148 | MP0000653_abnormal_sex_gland | 0.61239525 |
| 149 | MP0002928_abnormal_bile_duct | 0.61140057 |
| 150 | MP0003329_amyloid_beta_deposits | 0.61020609 |
| 151 | MP0000003_abnormal_adipose_tissue | 0.60715156 |
| 152 | MP0003699_abnormal_female_reproductive | 0.60300751 |
| 153 | MP0005451_abnormal_body_composition | 0.59985482 |
| 154 | MP0008469_abnormal_protein_level | 0.59982046 |
| 155 | MP0004782_abnormal_surfactant_physiolog | 0.59832972 |
| 156 | MP0005376_homeostasis/metabolism_phenot | 0.59670890 |
| 157 | MP0005248_abnormal_Harderian_gland | 0.59095031 |
| 158 | MP0006036_abnormal_mitochondrial_physio | 0.58996080 |
| 159 | MP0002970_abnormal_white_adipose | 0.58889583 |
| 160 | MP0009115_abnormal_fat_cell | 0.57741525 |
| 161 | MP0009672_abnormal_birth_weight | 0.57350854 |
| 162 | MP0009765_abnormal_xenobiotic_induced | 0.56816155 |
| 163 | MP0009384_cardiac_valve_regurgitation | 0.56431852 |
| 164 | MP0005167_abnormal_blood-brain_barrier | 0.56312598 |
| 165 | MP0002896_abnormal_bone_mineralization | 0.55213727 |
| 166 | MP0000639_abnormal_adrenal_gland | 0.55062620 |
| 167 | MP0002168_other_aberrant_phenotype | 0.53139421 |
| 168 | MP0005266_abnormal_metabolism | 0.52658350 |
| 169 | MP0000538_abnormal_urinary_bladder | 0.51766631 |
| 170 | MP0005187_abnormal_penis_morphology | 0.50972923 |
| 171 | MP0002837_dystrophic_cardiac_calcinosis | 0.49410737 |
| 172 | MP0003638_abnormal_response/metabolism_ | 0.49170551 |
| 173 | MP0000230_abnormal_systemic_arterial | 0.48676984 |
| 174 | MP0003566_abnormal_cell_adhesion | 0.48285811 |
| 175 | MP0000462_abnormal_digestive_system | 0.47953185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.99918081 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.84886287 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.69936587 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.55749068 |
| 5 | Xanthomatosis (HP:0000991) | 5.54880232 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.41795647 |
| 7 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.47923409 |
| 8 | Hypoglycemic coma (HP:0001325) | 4.37872810 |
| 9 | Abnormality of glycolysis (HP:0004366) | 4.31824560 |
| 10 | Ketosis (HP:0001946) | 4.27326208 |
| 11 | Hyperglycinuria (HP:0003108) | 4.26223957 |
| 12 | Complement deficiency (HP:0004431) | 4.23507552 |
| 13 | Increased serum pyruvate (HP:0003542) | 4.23233507 |
| 14 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.22310991 |
| 15 | Prolonged partial thromboplastin time (HP:0003645) | 4.20329279 |
| 16 | Epidermoid cyst (HP:0200040) | 4.20075510 |
| 17 | Hyperammonemia (HP:0001987) | 4.11346450 |
| 18 | Chromsome breakage (HP:0040012) | 4.09346705 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.08760799 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.02386612 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 4.02386612 |
| 22 | Hyperlipoproteinemia (HP:0010980) | 3.98359565 |
| 23 | Hyperglycinemia (HP:0002154) | 3.83378009 |
| 24 | Ketoacidosis (HP:0001993) | 3.77062336 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.74937760 |
| 26 | Fat malabsorption (HP:0002630) | 3.71933549 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.66249315 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.62774640 |
| 29 | Microvesicular hepatic steatosis (HP:0001414) | 3.55836936 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.48589696 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 3.44381044 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.32712829 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.26989715 |
| 34 | Gout (HP:0001997) | 3.26793301 |
| 35 | Abnormality of purine metabolism (HP:0004352) | 3.25035287 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.17205437 |
| 37 | Increased hepatocellular lipid droplets (HP:0006565) | 3.15267454 |
| 38 | Meckel diverticulum (HP:0002245) | 3.13429122 |
| 39 | Hypercholesterolemia (HP:0003124) | 3.10727085 |
| 40 | Abnormality of complement system (HP:0005339) | 3.08712311 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06451194 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.04327929 |
| 43 | Joint hemorrhage (HP:0005261) | 3.04317538 |
| 44 | Hypoglycemic seizures (HP:0002173) | 3.02488191 |
| 45 | Skin nodule (HP:0200036) | 2.98362307 |
| 46 | Abnormality of the ileum (HP:0001549) | 2.96818675 |
| 47 | Multiple enchondromatosis (HP:0005701) | 2.88232531 |
| 48 | Abnormal lung lobation (HP:0002101) | 2.87816195 |
| 49 | Spastic diplegia (HP:0001264) | 2.84958784 |
| 50 | Abnormality of the preputium (HP:0100587) | 2.84223126 |
| 51 | Hepatocellular carcinoma (HP:0001402) | 2.81779512 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 2.80117321 |
| 53 | Hydroxyprolinuria (HP:0003080) | 2.77208558 |
| 54 | Abnormality of proline metabolism (HP:0010907) | 2.77208558 |
| 55 | Lipid accumulation in hepatocytes (HP:0006561) | 2.75029439 |
| 56 | Microglossia (HP:0000171) | 2.73816928 |
| 57 | Myocardial infarction (HP:0001658) | 2.72494173 |
| 58 | Type I transferrin isoform profile (HP:0003642) | 2.71581816 |
| 59 | Abnormality of methionine metabolism (HP:0010901) | 2.69897084 |
| 60 | Late onset (HP:0003584) | 2.69736708 |
| 61 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.69283008 |
| 62 | Reticulocytopenia (HP:0001896) | 2.68098772 |
| 63 | Hyperbilirubinemia (HP:0002904) | 2.67503116 |
| 64 | Delayed CNS myelination (HP:0002188) | 2.65177259 |
| 65 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.62752666 |
| 66 | Increased nuchal translucency (HP:0010880) | 2.56759076 |
| 67 | Acanthocytosis (HP:0001927) | 2.56375601 |
| 68 | Malnutrition (HP:0004395) | 2.55333146 |
| 69 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.52622826 |
| 70 | Abnormal cartilage morphology (HP:0002763) | 2.49713806 |
| 71 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.49139817 |
| 72 | Metabolic acidosis (HP:0001942) | 2.46667310 |
| 73 | Abnormality of chromosome stability (HP:0003220) | 2.44338699 |
| 74 | Steatorrhea (HP:0002570) | 2.44135124 |
| 75 | Progressive external ophthalmoplegia (HP:0000590) | 2.43615112 |
| 76 | Proximal placement of thumb (HP:0009623) | 2.41960013 |
| 77 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.39185810 |
| 78 | Embryonal renal neoplasm (HP:0011794) | 2.36258321 |
| 79 | Progressive muscle weakness (HP:0003323) | 2.33897430 |
| 80 | Amniotic constriction ring (HP:0009775) | 2.33055501 |
| 81 | Abnormality of placental membranes (HP:0011409) | 2.33055501 |
| 82 | Deviation of the thumb (HP:0009603) | 2.31363299 |
| 83 | Abnormality of serum amino acid levels (HP:0003112) | 2.30636680 |
| 84 | Neonatal onset (HP:0003623) | 2.29177269 |
| 85 | Esophageal varix (HP:0002040) | 2.28365047 |
| 86 | Sensorimotor neuropathy (HP:0007141) | 2.26928440 |
| 87 | Generalized aminoaciduria (HP:0002909) | 2.26629835 |
| 88 | Macrocytic anemia (HP:0001972) | 2.24257101 |
| 89 | Increased serum lactate (HP:0002151) | 2.24248929 |
| 90 | Dicarboxylic aciduria (HP:0003215) | 2.23478988 |
| 91 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.23478988 |
| 92 | Duodenal stenosis (HP:0100867) | 2.22325108 |
| 93 | Small intestinal stenosis (HP:0012848) | 2.22325108 |
| 94 | Hyperglycemia (HP:0003074) | 2.22086411 |
| 95 | Hyperuricemia (HP:0002149) | 2.21832706 |
| 96 | Increased purine levels (HP:0004368) | 2.21832706 |
| 97 | Sparse eyelashes (HP:0000653) | 2.19354846 |
| 98 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.19313485 |
| 99 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.19313485 |
| 100 | Pancreatitis (HP:0001733) | 2.19175027 |
| 101 | Selective tooth agenesis (HP:0001592) | 2.18332810 |
| 102 | Irritability (HP:0000737) | 2.17973669 |
| 103 | Symptomatic seizures (HP:0011145) | 2.17685550 |
| 104 | Vascular calcification (HP:0004934) | 2.14104929 |
| 105 | Small epiphyses (HP:0010585) | 2.13660008 |
| 106 | Insomnia (HP:0100785) | 2.13620509 |
| 107 | Aplastic anemia (HP:0001915) | 2.11754764 |
| 108 | Back pain (HP:0003418) | 2.11715347 |
| 109 | Increased CSF lactate (HP:0002490) | 2.11346828 |
| 110 | Abnormal gallbladder morphology (HP:0012437) | 2.08245534 |
| 111 | Abnormal protein glycosylation (HP:0012346) | 2.08241285 |
| 112 | Abnormal glycosylation (HP:0012345) | 2.08241285 |
| 113 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.08241285 |
| 114 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.08241285 |
| 115 | Megaloblastic anemia (HP:0001889) | 2.06679083 |
| 116 | Postnatal microcephaly (HP:0005484) | 2.06315107 |
| 117 | Hepatocellular necrosis (HP:0001404) | 2.05027016 |
| 118 | Proximal tubulopathy (HP:0000114) | 2.04777495 |
| 119 | Hepatic necrosis (HP:0002605) | 2.04718082 |
| 120 | Acute necrotizing encephalopathy (HP:0006965) | 2.03553973 |
| 121 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.03164206 |
| 122 | Cardiovascular calcification (HP:0011915) | 2.02579607 |
| 123 | Overlapping toe (HP:0001845) | 2.01945468 |
| 124 | Mitral stenosis (HP:0001718) | 2.00249977 |
| 125 | Lethargy (HP:0001254) | 1.99558116 |
| 126 | Cholelithiasis (HP:0001081) | 1.98573371 |
| 127 | Lactic acidosis (HP:0003128) | 1.98043463 |
| 128 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.97960187 |
| 129 | Hemorrhage of the eye (HP:0011885) | 1.97955402 |
| 130 | Abnormality of the carotid arteries (HP:0005344) | 1.97638721 |
| 131 | Acute encephalopathy (HP:0006846) | 1.96721057 |
| 132 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96114009 |
| 133 | Cholecystitis (HP:0001082) | 1.95655992 |
| 134 | Abnormal gallbladder physiology (HP:0012438) | 1.95655992 |
| 135 | Missing ribs (HP:0000921) | 1.95416968 |
| 136 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.95208681 |
| 137 | Cerebral edema (HP:0002181) | 1.92626470 |
| 138 | Facial cleft (HP:0002006) | 1.92313014 |
| 139 | Rough bone trabeculation (HP:0100670) | 1.92294027 |
| 140 | Nephrolithiasis (HP:0000787) | 1.91158446 |
| 141 | Neoplasm of the colon (HP:0100273) | 1.91153731 |
| 142 | Lymphangioma (HP:0100764) | 1.91068711 |
| 143 | Turricephaly (HP:0000262) | 1.90957954 |
| 144 | Systemic lupus erythematosus (HP:0002725) | 1.90951123 |
| 145 | Abnormality of the anterior horn cell (HP:0006802) | 1.90913946 |
| 146 | Degeneration of anterior horn cells (HP:0002398) | 1.90913946 |
| 147 | Mitochondrial inheritance (HP:0001427) | 1.90822435 |
| 148 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.90787047 |
| 149 | Absent epiphyses (HP:0010577) | 1.90787047 |
| 150 | Alkalosis (HP:0001948) | 1.89999508 |
| 151 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.85826805 |
| 152 | Abnormal tarsal ossification (HP:0008369) | 1.84949216 |
| 153 | Insulin resistance (HP:0000855) | 1.84652219 |
| 154 | Poikiloderma (HP:0001029) | 1.84607147 |
| 155 | Horseshoe kidney (HP:0000085) | 1.83959068 |
| 156 | Increased intramyocellular lipid droplets (HP:0012240) | 1.83071400 |
| 157 | Irregular epiphyses (HP:0010582) | 1.82374540 |
| 158 | Premature ovarian failure (HP:0008209) | 1.81825344 |
| 159 | Rickets (HP:0002748) | 1.81561002 |
| 160 | Ileus (HP:0002595) | 1.81550914 |
| 161 | Myelodysplasia (HP:0002863) | 1.81110134 |
| 162 | Secondary amenorrhea (HP:0000869) | 1.81067090 |
| 163 | Abnormality of the Achilles tendon (HP:0005109) | 1.80697744 |
| 164 | Vomiting (HP:0002013) | 1.80407508 |
| 165 | Spontaneous abortion (HP:0005268) | 1.80113209 |
| 166 | Hypoplastic pelvis (HP:0008839) | 1.79113793 |
| 167 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.77539099 |
| 168 | Cortical dysplasia (HP:0002539) | 1.77040535 |
| 169 | Bifid tongue (HP:0010297) | 1.76977428 |
| 170 | Abnormality of the gallbladder (HP:0005264) | 1.76809948 |
| 171 | Brushfield spots (HP:0001088) | 1.76275481 |
| 172 | Neoplasm of the adrenal gland (HP:0100631) | 1.75950053 |
| 173 | Myoglobinuria (HP:0002913) | 1.75753833 |
| 174 | 11 pairs of ribs (HP:0000878) | 1.75724664 |
| 175 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.74550692 |
| 176 | Glomerulosclerosis (HP:0000096) | 1.74010672 |
| 177 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.73177944 |
| 178 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.73177944 |
| 179 | Glycosuria (HP:0003076) | 1.70157655 |
| 180 | Abnormality of urine glucose concentration (HP:0011016) | 1.70157655 |
| 181 | Elevated alkaline phosphatase (HP:0003155) | 1.70019539 |
| 182 | Exercise intolerance (HP:0003546) | 1.68322570 |
| 183 | Abnormality of the duodenum (HP:0002246) | 1.68319012 |
| 184 | Birth length less than 3rd percentile (HP:0003561) | 1.68075067 |
| 185 | Colon cancer (HP:0003003) | 1.66994296 |
| 186 | Absent radius (HP:0003974) | 1.65536139 |
| 187 | Trismus (HP:0000211) | 1.65401259 |
| 188 | Renal Fanconi syndrome (HP:0001994) | 1.64065946 |
| 189 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.62319866 |
| 190 | Confusion (HP:0001289) | 1.61813058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.34413033 |
| 2 | BCKDK | 4.32802800 |
| 3 | TRIB3 | 4.18012781 |
| 4 | PBK | 4.00670042 |
| 5 | ERN1 | 3.88181164 |
| 6 | SIK1 | 3.69109038 |
| 7 | MST4 | 3.50170370 |
| 8 | PKN2 | 3.42536687 |
| 9 | FRK | 3.29861085 |
| 10 | SRPK1 | 3.18055743 |
| 11 | VRK2 | 3.14217525 |
| 12 | CDC7 | 2.73323239 |
| 13 | EIF2AK1 | 2.73184478 |
| 14 | TTK | 2.66248522 |
| 15 | TSSK6 | 2.55702130 |
| 16 | FGFR4 | 2.50056142 |
| 17 | PTK6 | 2.33999535 |
| 18 | MST1R | 2.33073977 |
| 19 | WEE1 | 2.24773036 |
| 20 | INSRR | 2.22785123 |
| 21 | RIPK1 | 2.19263840 |
| 22 | LATS1 | 2.18658874 |
| 23 | TAOK3 | 2.18510157 |
| 24 | EIF2AK3 | 2.05070265 |
| 25 | NME2 | 1.98917441 |
| 26 | PLK3 | 1.74836033 |
| 27 | SCYL2 | 1.73876708 |
| 28 | MAP3K10 | 1.66482807 |
| 29 | MAP3K2 | 1.65842411 |
| 30 | PDGFRA | 1.62173618 |
| 31 | CAMK1D | 1.61866113 |
| 32 | LMTK2 | 1.61528532 |
| 33 | MAP3K12 | 1.60209119 |
| 34 | FLT3 | 1.59935599 |
| 35 | PLK4 | 1.53270456 |
| 36 | STK16 | 1.49198160 |
| 37 | STK39 | 1.44652547 |
| 38 | TAF1 | 1.43308876 |
| 39 | BRSK2 | 1.42241376 |
| 40 | EEF2K | 1.38175004 |
| 41 | PLK1 | 1.36520469 |
| 42 | BRSK1 | 1.36509771 |
| 43 | ERBB4 | 1.36509076 |
| 44 | MET | 1.35955065 |
| 45 | NME1 | 1.34959634 |
| 46 | ZAK | 1.32582495 |
| 47 | PTK2 | 1.30796097 |
| 48 | FGFR2 | 1.30518615 |
| 49 | NEK2 | 1.25958239 |
| 50 | VRK1 | 1.24773266 |
| 51 | LRRK2 | 1.24083119 |
| 52 | KSR2 | 1.20922344 |
| 53 | CCNB1 | 1.20673522 |
| 54 | AURKB | 1.19884243 |
| 55 | CDK7 | 1.18220324 |
| 56 | CHEK2 | 1.16328338 |
| 57 | BCR | 1.16136953 |
| 58 | MKNK1 | 1.15614947 |
| 59 | TRIM28 | 1.15042171 |
| 60 | CAMK1G | 1.09033278 |
| 61 | MAPK11 | 1.04926241 |
| 62 | CDK8 | 1.03117085 |
| 63 | NEK1 | 1.01394983 |
| 64 | EPHA2 | 1.00754001 |
| 65 | NEK9 | 1.00144823 |
| 66 | CDK6 | 0.98058686 |
| 67 | RET | 0.97467360 |
| 68 | WNK4 | 0.96880610 |
| 69 | SMG1 | 0.96113490 |
| 70 | ATR | 0.95772737 |
| 71 | FER | 0.95645695 |
| 72 | LIMK1 | 0.94981409 |
| 73 | EIF2AK2 | 0.94007441 |
| 74 | TNIK | 0.91583271 |
| 75 | PDK4 | 0.91510806 |
| 76 | PDK3 | 0.91510806 |
| 77 | MAP2K1 | 0.90972738 |
| 78 | TESK1 | 0.90936115 |
| 79 | JAK2 | 0.87647900 |
| 80 | LATS2 | 0.84218821 |
| 81 | MAP3K7 | 0.84142337 |
| 82 | MAP2K4 | 0.83876939 |
| 83 | BMX | 0.83220129 |
| 84 | EPHB2 | 0.83144286 |
| 85 | CSNK1A1L | 0.81769139 |
| 86 | PAK3 | 0.81397115 |
| 87 | MTOR | 0.80550814 |
| 88 | DAPK2 | 0.80279939 |
| 89 | TTN | 0.78458987 |
| 90 | CHEK1 | 0.78162400 |
| 91 | DYRK1B | 0.77829604 |
| 92 | MAP2K2 | 0.77299330 |
| 93 | PRKD3 | 0.76094340 |
| 94 | PASK | 0.74567560 |
| 95 | PIK3CG | 0.74226029 |
| 96 | PRKAA2 | 0.73058393 |
| 97 | ERBB2 | 0.72664356 |
| 98 | ERBB3 | 0.71916567 |
| 99 | CAMKK1 | 0.71798438 |
| 100 | FGFR1 | 0.70986095 |
| 101 | DAPK1 | 0.70930431 |
| 102 | KDR | 0.70676610 |
| 103 | NTRK1 | 0.69938173 |
| 104 | RPS6KB2 | 0.69472489 |
| 105 | PRKG2 | 0.68609174 |
| 106 | PRKAA1 | 0.68202204 |
| 107 | NUAK1 | 0.68065092 |
| 108 | PAK2 | 0.67315940 |
| 109 | FGFR3 | 0.67133178 |
| 110 | MKNK2 | 0.66750861 |
| 111 | ABL2 | 0.66690224 |
| 112 | DDR2 | 0.66013239 |
| 113 | AKT2 | 0.65835549 |
| 114 | BRD4 | 0.65518538 |
| 115 | AURKA | 0.65487737 |
| 116 | JAK1 | 0.65420761 |
| 117 | ALK | 0.64326995 |
| 118 | GSK3A | 0.63361129 |
| 119 | GRK6 | 0.63035355 |
| 120 | CSNK1G3 | 0.62476016 |
| 121 | MAP3K3 | 0.60658502 |
| 122 | STK38L | 0.57836231 |
| 123 | EPHB1 | 0.56858652 |
| 124 | MAP3K1 | 0.56372785 |
| 125 | MAP3K8 | 0.55902249 |
| 126 | PDPK1 | 0.55744036 |
| 127 | ATM | 0.55651476 |
| 128 | CSNK2A2 | 0.54967515 |
| 129 | PNCK | 0.54206318 |
| 130 | CSNK1G1 | 0.53723943 |
| 131 | CDK9 | 0.53474401 |
| 132 | STK3 | 0.53416431 |
| 133 | PAK4 | 0.50897758 |
| 134 | STK4 | 0.50621452 |
| 135 | TYK2 | 0.50311791 |
| 136 | CDK18 | 0.48905589 |
| 137 | STK10 | 0.48213826 |
| 138 | PRKACG | 0.48095008 |
| 139 | PDGFRB | 0.48035831 |
| 140 | MAPKAPK3 | 0.46553829 |
| 141 | PRKCZ | 0.46430525 |
| 142 | MELK | 0.45981270 |
| 143 | CSNK2A1 | 0.45708691 |
| 144 | AKT3 | 0.45275098 |
| 145 | CDK14 | 0.44587962 |
| 146 | CDK4 | 0.44173957 |
| 147 | CDK15 | 0.43929605 |
| 148 | CDK12 | 0.43600332 |
| 149 | TESK2 | 0.42847417 |
| 150 | MAP2K3 | 0.42727452 |
| 151 | CDK1 | 0.42379081 |
| 152 | PRKCH | 0.42223944 |
| 153 | CDK11A | 0.40908396 |
| 154 | RPS6KA4 | 0.40808640 |
| 155 | SGK3 | 0.40126268 |
| 156 | PDK2 | 0.39672081 |
| 157 | TAOK1 | 0.38921957 |
| 158 | CSNK1E | 0.38805847 |
| 159 | MAPKAPK5 | 0.38582248 |
| 160 | TIE1 | 0.37953398 |
| 161 | ARAF | 0.36346049 |
| 162 | PDK1 | 0.36029575 |
| 163 | ICK | 0.35805917 |
| 164 | IGF1R | 0.34854451 |
| 165 | MAP3K9 | 0.34392351 |
| 166 | CSNK1G2 | 0.33922893 |
| 167 | CDK2 | 0.33022328 |
| 168 | EGFR | 0.32892460 |
| 169 | BMPR1B | 0.31860859 |
| 170 | NEK6 | 0.28787988 |
| 171 | PRKD1 | 0.28190358 |
| 172 | WNK3 | 0.27962537 |
| 173 | TBK1 | 0.27585610 |
| 174 | EPHA3 | 0.25143725 |
| 175 | MAP3K11 | 0.24347543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.90048403 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.82160612 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.65850393 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.60666273 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.35053464 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 3.16820040 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.85185510 |
| 8 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.76944055 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.76664605 |
| 10 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.69733962 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67422900 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65924264 |
| 13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.64333861 |
| 14 | Spliceosome_Homo sapiens_hsa03040 | 2.61870715 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61044354 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.59507931 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 2.39264696 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.37766540 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.29646973 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 2.28339530 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24600109 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.19655511 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18176406 |
| 24 | RNA polymerase_Homo sapiens_hsa03020 | 2.16055039 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.10394251 |
| 26 | RNA transport_Homo sapiens_hsa03013 | 2.09753805 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.09242245 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.05823567 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.99942326 |
| 30 | Homologous recombination_Homo sapiens_hsa03440 | 1.99811744 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.96467628 |
| 32 | Cell cycle_Homo sapiens_hsa04110 | 1.96386204 |
| 33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.86693064 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.86276270 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.86216171 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.78448742 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74499300 |
| 38 | Protein export_Homo sapiens_hsa03060 | 1.74142068 |
| 39 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.72764654 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.68438039 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.67788847 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.65056138 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62536991 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.60886575 |
| 45 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.60507496 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.59422894 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.56664476 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.56073905 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.54026286 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.53454926 |
| 51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.52170249 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.52102775 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.44330772 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43787285 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40818619 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.38965008 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.37397678 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35546495 |
| 59 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.33611763 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30334463 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 1.29186724 |
| 62 | Parkinsons disease_Homo sapiens_hsa05012 | 1.28389335 |
| 63 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26900204 |
| 64 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.18916740 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18355764 |
| 66 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14377574 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 1.13065067 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 1.10065800 |
| 69 | Purine metabolism_Homo sapiens_hsa00230 | 1.08251901 |
| 70 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07605835 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.03922389 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03223944 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.02873078 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02386337 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01582986 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.00491484 |
| 77 | Huntingtons disease_Homo sapiens_hsa05016 | 0.98281644 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96322619 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.93374933 |
| 80 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84417554 |
| 81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.84045757 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83910365 |
| 83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.82629748 |
| 84 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.80916024 |
| 85 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77102441 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70798034 |
| 87 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.70378699 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66646448 |
| 89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.66256660 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64924801 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64055051 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63824675 |
| 93 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61437213 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.57832389 |
| 95 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.57180676 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56676552 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56299775 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52961855 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49371411 |
| 100 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.48816492 |
| 101 | Adherens junction_Homo sapiens_hsa04520 | 0.48578654 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47464896 |
| 103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46043255 |
| 104 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44803470 |
| 105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44676344 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44547009 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42967566 |
| 108 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.41632696 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41031227 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36769173 |
| 111 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35334084 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34883962 |
| 113 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.32939342 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31539113 |
| 115 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31472251 |
| 116 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30291708 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.28059638 |
| 118 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.28032310 |
| 119 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.27024314 |
| 120 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.26588967 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.26380834 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.23239241 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22239571 |
| 124 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.21627275 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.20967549 |
| 126 | Tight junction_Homo sapiens_hsa04530 | 0.20001554 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.19966004 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.19806581 |
| 129 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.19352273 |
| 130 | Shigellosis_Homo sapiens_hsa05131 | 0.19321722 |
| 131 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.19026813 |
| 132 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.18890462 |
| 133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15995397 |
| 134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10705863 |
| 135 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.07317945 |
| 136 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.05191286 |
| 137 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03724613 |
| 138 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.02935294 |
| 139 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.00777542 |
| 140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.00190828 |
| 141 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0525516 |
| 142 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0509706 |
| 143 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0501473 |
| 144 | Lysosome_Homo sapiens_hsa04142 | -0.0459306 |
| 145 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.0440236 |
| 146 | Amoebiasis_Homo sapiens_hsa05146 | -0.0324012 |
| 147 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0320626 |

